Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

“Oral health behaviors are linked to inflammation and artery hardening. Flossing may reduce stroke risk by lowering oral ...

Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...

Intensive BP lowering after successful endovascular thrombectomy for acute anterior circulation ischemic stroke did not improve 90-day functional outcomes vs. standard BP control, a speaker ...

University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

Medtronic announced that new findings from the company-sponsored DiVERT Stroke clinical study showed women spent less time in t ...

People with shorter telomeres, the protective caps at the end of chromosomes, inside their white blood cells may be more ...

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...

University of Calgary researchers with the Calgary Stroke Program continue to advance the science to determine best ...